The Chemistry-Biochemistry-Biology Interface (CBBI) Program at the University of Notre Dame is an established NIH-funded program, which trains graduate students in a multidisciplinary environment and provides them with significant training in a cross-discipline at the interface of chemistry, biochemistry, and biology. The goal of the CBBI Program is to produce Ph.D. scientists who have in-depth training in the student's core discipline, cross-discipline training to work effectively at the interface, and enhanced interdisciplinary communication skills. The CBBI Program has been successful and has established an outstanding training environment for our Ph.D. students. During the past four years, we have trained 25 students (who were recipients of 41 one-year fellowships, 18 provided by the NIH and 23 by Notre Dame in matching support of this training grant), including 4 underrepresented minorities (URMs). Six trainees have completed the program with Ph.D. degrees, an additional 5 trainees will be receiving their Ph.D. degrees in 2011, and the remaining trainees are on track to complete their Ph.D. degrees. The characteristics of the CBBI Program include: a large applicant pool of highly qualified candidates, a strong record of collaborative and multidisciplinary research, a diverse and strong group of experienced, productive, and federally-funded investigators available to serve as research mentors, a hallmark extended cross-disciplinary research internship outside the mentor's laboratory, training supplementation with multidisciplinary seminars, trainee meetings, and an annual symposium, experienced and effective program administration, mechanisms for continuous evaluation and improvement of the training program, professional development and career placement, a summer research program to attract and retain underrepresented minorities, excellent research facilities, and strong institutional commitment. We propose to continue to train Ph.D. scientists with the skills and expertise to solve complex biomedical problems, regardless of discipline. The University of Notre Dame enthusiastically supports this training program, and will continue to provide a generous fellowship match and additional funds in support of the CBBI Program upon its funding renewal by the NIH.

Public Health Relevance

Cutting-edge biomedical research is highly multidisciplinary, requiring contributions from a diverse group of scientists. The Chemistry-Biochemistry-Biology Interface (CBBI) Program at the University of Notre Dame has met this need for cross-disciplinary training and produced researchers with a synergistic combination of scientific skills and expertise, broad knowledge across diverse scientific disciplines, and excellent communication skills. Our goal is to continue to train scientists with the skills and expertise to solve biomedical problems, regardless of discipline.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Fabian, Miles
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Notre Dame
Schools of Arts and Sciences
Notre Dame
United States
Zip Code
Rosales, Anthony R; Quinn, Taylor R; Wahlers, Jessica et al. (2018) Application of Q2MM to predictions in stereoselective synthesis. Chem Commun (Camb) 54:8294-8311
Lee, Mijoon; Batuecas, MarĂ­a T; Tomoshige, Shusuke et al. (2018) Exolytic and endolytic turnover of peptidoglycan by lytic transglycosylase Slt of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 115:4393-4398
Bouchard, Jill J; Xia, Junchao; Case, David A et al. (2018) Enhanced Sampling of Interdomain Motion Using Map-Restrained Langevin Dynamics and NMR: Application to Pin1. J Mol Biol 430:2164-2180
Tomoshige, Shusuke; Dik, David A; Akabane-Nakata, Masaaki et al. (2018) Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the ?-Lactam Antibiotics. ACS Infect Dis 4:860-867
Shaw, Scott K; Schreiber, Cynthia L; Roland, Felicia M et al. (2018) High expression of integrin ?v?3 enables uptake of targeted fluorescent probes into ovarian cancer cells and tumors. Bioorg Med Chem 26:2085-2091
Nguyen, Trung T; Ding, Derong; Wolter, William R et al. (2018) Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers. Eur J Pharmacol 834:77-83
Del Vecchio, Kathryn; Stahelin, Robert V (2018) Investigation of the phosphatidylserine binding properties of the lipid biosensor, Lactadherin C2 (LactC2), in different membrane environments. J Bioenerg Biomembr 50:1-10
Byun, Byungjin; Mahasenan, Kiran V; Dik, David A et al. (2018) Mechanism of the Escherichia coli MltE lytic transglycosylase, the cell-wall-penetrating enzyme for Type VI secretion system assembly. Sci Rep 8:4110
Del Vecchio, Kathryn; Frick, Cary T; Gc, Jeevan B et al. (2018) A cationic, C-terminal patch and structural rearrangements in Ebola virus matrix VP40 protein control its interactions with phosphatidylserine. J Biol Chem 293:3335-3349
Kane, Trevor L; Carothers, Katelyn E; Lee, Shaun W (2018) Virulence Factor Targeting of the Bacterial Pathogen Staphylococcus aureus for Vaccine and Therapeutics. Curr Drug Targets 19:111-127

Showing the most recent 10 out of 191 publications